Bio-Rad Laboratories, Inc. (BIO-B)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous Close | 279.91 |
| Open | 281.55 |
| Bid | 281.45 x 1400 |
| Ask | 282.83 x 800 |
| Day's Range | 279.91 - 281.55 |
| 52 Week Range | 271.00 - 387.55 |
| Volume | |
| Avg. Volume | 270 |
| Market Cap | 7.923B |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.69 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results
The first-quarter results for Bio-Rad Laboratories, Inc. ( NYSE:BIO ) were released last week, making it a good time to...
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
© 2024 Yahoo. All rights reserved.